Helsinki University Central Hospital
Clinical trials sponsored by Helsinki University Central Hospital, explained in plain language.
-
Sinus surgery showdown: crush vs. cut for better breathing
Disease control CompletedThis study compared two surgical techniques for treating concha bullosa, a condition where the middle nasal turbinate is enlarged with air. Researchers followed 62 patients with chronic sinusitis who underwent sinus surgery, randomly assigning them to either have the enlarged tis…
Phase: NA • Sponsor: Helsinki University Central Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Counseling program aims to stop Kids' cavities from coming back
Disease control CompletedThis study tested whether counseling from a pediatrician and social worker could help families keep follow-up dental appointments after their young children had cavities treated under general anesthesia. Researchers worked with 89 families in Finland to see if this support would …
Phase: NA • Sponsor: Helsinki University Central Hospital • Aim: Disease control
Last updated Mar 06, 2026 15:38 UTC
-
Grapefruit juice tested for impact on depression drug
Knowledge-focused CompletedThis study looked at how grapefruit juice and another medication affect how the body processes esketamine, a drug used for depression and pain. Researchers gave 12 healthy volunteers esketamine either as a nasal spray or by mouth, along with either grapefruit juice, the other med…
Phase: PHASE1 • Sponsor: Helsinki University Central Hospital • Aim: Knowledge-focused
Last updated Apr 04, 2026 08:51 UTC
-
Common heart and pain pills could change how your body handles other drugs
Knowledge-focused CompletedThis study aims to understand if two widely used medications—carvedilol (for heart conditions) and diclofenac (an anti-inflammatory painkiller)—affect how the body breaks down other drugs. Researchers gave 12 healthy volunteers a combination of several low-dose 'probe' drugs, alo…
Phase: NA • Sponsor: Helsinki University Central Hospital • Aim: Knowledge-focused
Last updated Apr 04, 2026 08:50 UTC
-
Aggravated airway inflammation: research on biological treatment (Mepolizumab)
CompletedPrimary objective: to investigate the efficacy of Mepolizumab 100 milligram (mg) every month compared to placebo in reducing validated Sinonasal Outcome Test -22 score and on reducing endoscopic Nasal Polyp Score. The participants have a triad of chronic rhinosinusitis with nasa…
Phase: PHASE4 • Sponsor: Helsinki University Central Hospital
Last updated Apr 03, 2026 14:42 UTC